1-4 of 4
Sara Yousef
Close
Sort by
Journal Articles

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sebastian Bunk, PhD, Martin Hofmann, PhD, Felix Unverdorben, PhD, Meike Hutt, PhD, Gabriele Pszolla, PhD, Frank Schwöbel, PhD, Claudia Wagner, PhD, Sara Yousef, PhD, Heiko Schuster, PhD, Sarah Missel, PhD, Oliver Schoor, PhD, Toni Weinschenk, PhD, Harpreet Singh-Jasuja, PhD, Dominik Maurer, PhD, Carsten Reinhardt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3368.
https://doi.org/10.1182/blood-2019-129958
Published: 2019
Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma

Sabarinath Venniyil Radhakrishnan, MBBS, MD, Tim Luetkens, MD, Sara Yousef, PhD, Neelam Bhardwaj, PhD, Mary Nicole Steinbach, NP, Janet Weidner, Christa Shorter, BSc, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3142.
https://doi.org/10.1182/blood.V130.Suppl_1.3142.3142
Published: 2017
Journal Articles

"In Vivo Vaccination" Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab

Tim Luetkens, MD, Sara Yousef, PhD, Christa Shorter, BSc, Srinivas K. Tantravahi, MBBS, Mary Nicole Steinbach, NP, Janet Weidner, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1830.
https://doi.org/10.1182/blood.V130.Suppl_1.1830.1830
Published: 2017
Journal Articles

Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma

Nesrine Lajmi, Julia Templin, Sara Yousef, Tim Luetkens, Stefanie Spock, York Hildebrandt, Katrin Bartels, Yanran Cao, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic
Journal: Blood
Blood (2012) 120 (21): 1808.
https://doi.org/10.1182/blood.V120.21.1808.1808
Published: 2012